Obese or Overweight Healthy Volunteers

2

Review clinical trials related to Obese or Overweight Healthy Volunteers. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

The purpose of this study is to: * evaluate the safety and tolerability of single ascending doses of ALN-4324 in healthy volunteers and to characterize the single-dose PK of ALN-4324 * evaluate the efficacy, safety, tolerability, and pharmacodynamics (PD) of multiple doses of ALN-4324 in adult overweight to obese patients with T2DM

Participants needed: 144
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Alnylam PharmaceuticalsUpdated: Jun 12, 2026Locations: 22
Eligibility criteria

Has a body mass index (BMI) of ≥27 kg/m² and <40 kg/m² [+4]

Has known human immunodeficiency virus (HIV) infection; or known current or chro... [+1]

Status: Not yet recruiting

Clinical Study to Assess the Safety and Efficacy of ACV Moringa Effervescent Tablet Intake on Weight Management in Overweight and Class I Obese Study Participants

A Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Single-Centre, Clinical Study to Evaluate the Safety and Efficacy of Intake of ACV Moringa on the Degree of Weight Change in Overweight and Class I Obese Study Participants

Participants needed: 66
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: NovoBliss Research Pvt LtdUpdated: Aug 1, 2025
Eligibility criteria

Age: 18- 65 years (both inclusive) at the time of consent. [+17]

Subjects BMI is between less than 25 and greater than 35 kg/m2. [+22]